These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8758508)

  • 1. [Acute myelitis after immunization against hepatitis B with recombinant vaccine].
    Senejoux A; Roulot D; Belin C; Tsakiris L; Rautureau J; Coste T
    Gastroenterol Clin Biol; 1996; 20(4):401-2. PubMed ID: 8758508
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative efficacy of two dosages of recombinant hepatitis B vaccine in healthy adolescents in India.
    Velu V; Nandakumar S; Shanmugam S; Shankar EM; Thangavel S; Kulkarni PS; Thyagarajan SP
    Pediatr Infect Dis J; 2007 Nov; 26(11):1038-41. PubMed ID: 17984812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to recombinant hepatitis B vaccine in children and adolescents with chronic renal failure.
    Watkins SL; Alexander SR; Brewer ED; Hesley TM; West DJ; Chan IS; Mendelman P; Bailey SM; Burns JL; Hogg RJ;
    Am J Kidney Dis; 2002 Aug; 40(2):365-72. PubMed ID: 12148110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute myelitis after vaccination against hepatitis B].
    Mahassin F; Algayres JP; Valmary J; Bili H; Coutant G; Bequet D; Daly JP
    Presse Med; 1993 Dec; 22(40):1997-8. PubMed ID: 8127802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrotic syndrome after recombinant hepatitis B vaccine.
    Macário F; Freitas L; Correia J; Campos M; Marques A
    Clin Nephrol; 1995 May; 43(5):349. PubMed ID: 7634556
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of thiomersal-free and thiomersal-containing formulations of a recombinant hepatitis B vaccine (Hepavax-Gene) in healthy adults.
    Rebedea I; Diaconescu IG; Bach D; Bartelsen O; Arndtz N
    Vaccine; 2006 Jun; 24(25):5320-6. PubMed ID: 16707195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of HB vaccine].
    Sodeyama T; Kobayashi M
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():216-21. PubMed ID: 15453318
    [No Abstract]   [Full Text] [Related]  

  • 8. Prophylactic recombinant hepatitis B vaccine in patients undergoing orthotopic liver transplantation.
    Berner J; Kadian M; Post J; Miller C; Schwartz M; Conn M; Borcich A
    Transplant Proc; 1993 Apr; 25(2):1751-2. PubMed ID: 8470152
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunogenicity and reactogenicity of two recombinant hepatitis B vaccines in small infants: a randomized, double-blind comparative study.
    Sapru A; Kulkarni PS; Bhave S; Bavdekar A; Naik SS; Pandit AN
    J Trop Pediatr; 2007 Oct; 53(5):303-7. PubMed ID: 17478542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Causative immunopathologic mechanisms in pediatric urticaria following primary injection with anti-hepatitis B vaccine].
    Barbaud A; Reichert-Pénétrat S; Béné MC; Kolopp-Sarda MN; Faure G; Kohler C; Schmutz JL
    Ann Dermatol Venereol; 2000; 127(6-7):662-3. PubMed ID: 11041825
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens.
    Betancourt AA; Delgado CA; Estévez ZC; Martínez JC; Ríos GV; Aureoles-Roselló SR; Zaldívar RA; Guzmán MA; Baile NF; Reyes PA; Ruano LO; Fernández AC; Lobaina-Matos Y; Fernández AD; Madrazo AI; Martínez MI; Baños ML; Alvarez NP; Baldo MD; Mestre RE; Pérez MV; Martínez ME; Escobar DA; Guanche MJ; Cáceres LM; Betancourt RS; Rando EH; Nieto GE; González VL; Rubido JC
    Int J Infect Dis; 2007 Sep; 11(5):394-401. PubMed ID: 17257877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of indigenous recombinant hepatitis B vaccine in infants following a 0, 1, 2-month vaccination schedule.
    Kumar TS; Abraham P; Raghuraman S; Cherian T
    Indian Pediatr; 2000 Jan; 37(1):75-80. PubMed ID: 10745392
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibody responses to intradermal recombinant hepatitis B immunization among HIV-positive subjects.
    Ristola MA; Vuola JM; Valle M; von Reyn CF
    Vaccine; 2004 Nov; 23(2):205-9. PubMed ID: 15531038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why do we need a newer generation of recombinant vaccines against hepatitis B?
    Chalasani N; Gitlin N
    Am J Gastroenterol; 1997 Dec; 92(12):2314-5. PubMed ID: 9399785
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunogenicity and safety assessment of the Cuban recombinant hepatitis B vaccine in healthy adults.
    Estévez ZC; Betancourt AA; Muzio González V; Baile NF; Silva CV; Bernal FH; Arias EP; Delhanty Fernández A; Olazábal NM; del Río Martín A; Batista LL; Véliz Ríos G; Hernández HH; Hernández AB; Lugo EP; de la Torre Cruz J; Batista Marchec BL; Falcón LA; Brito JT; León DO; Saura PL
    Biologicals; 2007 Apr; 35(2):115-22. PubMed ID: 17056272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bivalent inactivated hepatitis A and recombinant hepatitis B vaccine.
    Beran J
    Expert Rev Vaccines; 2007 Dec; 6(6):891-902. PubMed ID: 18377352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New vaccination strategies for low- and non-responders to hepatitis B vaccine.
    Rendi-Wagner P; Wiedermann G; Stemberger H; Kollaritsch H
    Wien Klin Wochenschr; 2002 Mar; 114(5-6):175-80. PubMed ID: 12238305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination against hepatitis B virus in children and adolescents in a pediatric hospital.
    Catania G; Di Ciommo V; Concato C
    Recenti Prog Med; 1996 Jun; 87(6):271-4. PubMed ID: 8766952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth.
    Carniel EF; Morcillo AM; Blotta MH; Da Silva MT; Mazzola TN; Antonio MA; Zanolli ML; Netto AA; Higashi HG; Raw I; Vilela MM
    Vaccine; 2008 Jan; 26(5):647-52. PubMed ID: 18155811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immediate immunological effect of China-made recombinant hepatitis B vaccine expressed by transgenic Chinese hamster ovary cell line].
    Liu H; Ma J; Meng Z; Zhang Y; Han C; Zhang Y; Zhao H; Liu Y; Xing Z; Chen J; Jia Z; Xia G; Cao H; Liu C; Li Z
    Zhonghua Yi Xue Za Zhi; 2002 Jan; 82(1):43-6. PubMed ID: 11953126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.